Article

Vision quality is patients' top priority when choosing products

Product benefits relating to vision quality top the list of considerations when patients whose vision has been corrected select eye-care products, according to the Needs, Symptoms, Incidence, Global Eye Health Trends (NSIGHT) study.

Rochester, NY-Product benefits relating to vision quality top the list of considerations when patients whose vision has been corrected select eye-care products, according to the Needs, Symptoms, Incidence, Global Eye Health Trends (NSIGHT) study.

The NSIGHT study, commissioned by Bausch + Lomb and conducted by Market Probe: Europe, an independent market research firm, surveyed 3,800 spectacle- and contact lens-wearing patients aged 15 to 65 years, from seven countries (China, Korea, Japan, France, Italy, the United Kingdom, and the United States). It aimed to determine a hierarchy of patient needs in the selection of eye-related products, based on respondents’ scoring of 40 features representing eight categories of potential product features.

The study revealed that product benefits relating to vision quality are highly important to patients all around the world. When patients are asked to trade off various functional needs relative to eye-care products, comfort becomes only half as important as vision quality.

The eight categories of eye-care product benefits, in descending order of importance to patients, were vision, health, environment, eye condition, convenience, comfort, personal performance, and personal appearance.

"NSIGHT validated that clear, crisp vision is a top priority for our patients,” said Carla Mack, OD, FAAO, director, global medical affairs, Bausch + Lomb.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
© 2025 MJH Life Sciences

All rights reserved.